Company news
Collplant Biotechnologies Ltd. (NASDAQ:CLGN) news
Every Collplant Biotechnologies Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
March 28, 2021
CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
March 25, 2021
CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference
March 3, 2021
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants
February 24, 2021
CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares
February 17, 2021
CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares
February 10, 2021
CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
February 7, 2021
CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications
December 9, 2020
CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update
November 30, 2020
CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients
November 9, 2020
CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine
October 25, 2020
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
September 20, 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
September 13, 2020
CollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results
August 27, 2020
CollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results
May 26, 2020
CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019
March 31, 2020
CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement
February 13, 2020
CollPlant Partners in the Advanced Regenerative Manufacturing Institute
January 5, 2020
CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update
November 28, 2019
CollPlant Biotechnologies Closes on $5.5 Million Financing
September 8, 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
June 19, 2019
CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update
May 29, 2019
CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece
May 27, 2019
CollPlant Launches New HQ and R&D Center in Israel
May 21, 2019
CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care
April 23, 2019
CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City
April 22, 2019
CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
March 31, 2019